Alvotech (ALVO) Operating Leases (2020 - 2026)
Alvotech's (ALVO) quarterly Operating Leases came in at $134.0 million in Q2 2026, down 1.69% on a YoY basis from $136.3 million in Q2 2025, and little changed quarter-over-quarter from $134.5 million in Q1 2026.
Analysis
Alvotech (ALVO) Operating Leases (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Operating Leases for 7 consecutive years, with $134.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases fell 1.69% year-over-year to $134.0 million; the trailing twelve-month figure through Jun 2026 stood at $134.0 million (down 1.69% YoY), and the FY2025 full-year result was $138.0 million, up 23.06% from the prior year.
- Operating Leases steadied at $134.0 million in Q2 2026 per ALVO's latest filing, from $134.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $144.5 million in Q3 2025 and bottomed at $40.5 million in Q4 2022.
- Historically, Operating Leases has averaged $118.5 million across 5 years, with a median of $120.5 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Operating Leases slumped 66.82% in 2022, then soared 184.5% in 2023.
- Over 5 years, Operating Leases stood at $40.5 million in 2022, then jumped by 184.5% to $115.3 million in 2023, then fell by 2.76% to $112.1 million in 2024, then rose by 23.06% to $138.0 million in 2025, then dropped by 2.93% to $134.0 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $134.0 million, $134.5 million, and $138.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.96 Mn |
| Mar 31, 2026 | 134.52 Mn |
| Dec 31, 2025 | 138.00 Mn |
| Sep 30, 2025 | 144.52 Mn |
| Jun 30, 2025 | 136.26 Mn |
| Mar 31, 2025 | 119.15 Mn |
| Dec 31, 2024 | 112.14 Mn |
| Sep 30, 2024 | 140.76 Mn |
| Jun 30, 2024 | 121.87 Mn |
| Mar 31, 2024 | 110.59 Mn |
| Dec 31, 2023 | 115.32 Mn |
| Jun 30, 2023 | 95.40 Mn |
| Dec 31, 2022 | 40.53 Mn |
| Jun 30, 2022 | 115.30 Mn |
| Dec 31, 2021 | 122.14 Mn |
| Dec 31, 2020 | 108.95 Mn |